Biotech gains DSMB approval to escalate dosing a
Author: Michael
Research also identifies key methylation sites,
Berlin’s YEARS clinic analyzes patient health
Pfizer and Lilly join investors in biotech seeki
ChromaDex CEO Rob Fried on the importance of NAD
Public offering supports trials of gene therapie
Exclusive event will showcase the latest innovat
Key de-extinction breakthrough leverages gene ed
Company unveils PeptiSleep, a rice bran-derived
Biograph leverages advanced diagnostics focused